naltrexone
Ligand Summary
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
UNII: 5S6W795CQM
PubChem: 5360515
Guide to Pharmacology: 1639
ChEMBL: CHEMBL19019
DrugCentral: 1765
LyCHI: MT269CKQJVMQ
Target Activities
142 Activities
Items per page:
1 – 10 of 142
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
Kd | ||||||
EC50 | ||||||
EC50 | ||||||
IC50 | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||